CYTH stock forecast for 2023 – 2027

Are you interested in Cyclo Therapeutics, Inc. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the CYTH stock price in 2022-2027. Is CYTH a good long term stock? When should I take profit in Cyclo Therapeutics stock? Buy or sell stock? Will CYTH stock price go up? What are analysts’ forecasts for CYTH stock?
Forecst.com predicts future values using technical analysis of a large number of analytical parameters. CYTH stock returns are also predicted based on historical data.

According to our research, CYTH stock is a bad long-term investment. CYTH share price has been in a bear cycle for the past year. Cyclo Therapeutics, Inc. stock trend is negative.

Cyclo Therapeutics company info

Industry Drug Manufacturers—Specialty & Generic
Address 6714 NW 16th Street, Gainesville, FL, 32653, United States
Website https://www.cyclotherapeutics.com

Forecasting

52 Week High: 4.11672 USD
52 Week Low: 0.061 USD
1 Year Forecast: 0.21582 USD
5 Year Forecast: 0 USD

Agilent Technologies info

Market Cap: 23.76M
52 Week Change: -3.185%
52 Week High: 17.75 USD
52 Week Low: 3.4 USD
Beta: 1.43578
50 Day Moving Average: 4.02
90 Day Moving Average: 4.811
200 Day Moving Average: 6.2
Resistance Level: 3.79064
Pivot Point: 3.68852
Support Level: 3.53226
Enterprise Value: 19,556,328
Forward P/E: -2.25
Forward EPS: -1.61
Profit Margin: 0.00%
Shares Outstanding: 8,405,220
EBITDA: -1.38
Held Percent Institutions: 3.94%
PEG Ratio (5Y): 0
Trailing EPS: -2.808

Cyclo Therapeutics stock forecasts for 2023-2027

DateOpen PriceClose PriceChange

Cyclo Therapeutics Stock Forecast for 2023

January 2023 0 0 0%
February 2023 0 0 0%
March 2023 0 0 0%
April 2023 0 0 0%
May 2023 0 0 0%
June 2023 0 0 0%
July 2023 0 0 0%
August 2023 0 0 0%
September 2023 0 0 0%
October 2023 0 0 0%
November 2023 0 0 0%
December 2023 0 0 0%

Cyclo Therapeutics Stock Forecast for 2024

January 2024 0 0 0%
February 2024 0 0 0%
March 2024 0 0 0%
April 2024 0 0 0%
May 2024 0 0 0%

Other companies stock forecasts